CIK 0001446847
- Accelerated filer
- Smaller reporting company
IRONWOOD PHARMACEUTICALS INC
Sign in to watch- Ticker
- IRWD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 043404176
- Phone
- +1 617-621-7722
- Business address
- 100 SUMMER STREET, SUITE 2300, BOSTON, MA, 02110
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-03-08 | MCCOURT Thomas A Chief Executive Officer | Grant or award | +240,595 | 888,193 | ||
| 2023-03-08 | MCCOURT Thomas A Chief Executive Officer | Grant or award · Performance-based Restricted Stock Units | +120,297 | 120,297 | ||
| 2023-03-08 | Emany Sravan Kumar SVP, Chief Financial Officer | Grant or award | +74,236 | 152,658 | ||
| 2023-03-08 | Emany Sravan Kumar SVP, Chief Financial Officer | Grant or award · Performance-based Restricted Stock Units | +37,118 | 37,118 | ||
| 2023-03-08 | Davis Andrew SVP, Chief Business Officer | Grant or award | +74,236 | 225,632 | ||
| 2023-03-08 | Davis Andrew SVP, Chief Business Officer | Grant or award · Performance-based Restricted Stock Units | +37,118 | 37,118 | ||
| 2023-03-03 | MCCOURT Thomas A Chief Executive Officer | Sale | −33,756 | $11.22 | $379K | 647,598 |
| 2023-02-28 | Silver Ronald Principal Accounting Officer | Sale | −3,049 | $11.31 | $34K | 98,491 |
| 2023-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −13,987 | $11.31 | $158K | 336,090 |
| 2023-02-28 | Rickard Jason SVP, Chief Operating Officer | Sale | −3,442 | $11.31 | $39K | 332,648 |
| 2023-02-28 | MCCOURT Thomas A Chief Executive Officer | Sale | −26,639 | $11.31 | $301K | 685,942 |
| 2023-02-28 | MCCOURT Thomas A Chief Executive Officer | Sale | −4,588 | $11.31 | $52K | 681,354 |
| 2023-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −7,438 | $11.31 | $84K | 264,002 |
| 2023-02-28 | Shetzline Michael CMO,SVP,Head-Res&Drug | Sale | −2,416 | $11.31 | $27K | 261,586 |
| 2023-02-28 | John Minardo Chief Legal Officer | Sale | −3,415 | $11.31 | $39K | 133,738 |
| 2023-02-28 | Davis Andrew SVP, Chief Business Officer | Sale | −1,822 | $11.31 | $21K | 151,396 |
| 2023-02-27 | Silver Ronald Principal Accounting Officer | Sale | −2,929 | $11.41 | $33K | 101,540 |
| 2023-02-27 | Rickard Jason SVP, Chief Operating Officer | Sale | −13,438 | $11.41 | $153K | 353,385 |
| 2023-02-27 | Rickard Jason SVP, Chief Operating Officer | Sale | −3,308 | $11.41 | $38K | 350,077 |
| 2023-02-27 | MCCOURT Thomas A Chief Executive Officer | Sale | −25,595 | $11.41 | $292K | 716,990 |
Page 9 of 14 · 274 trades